Tocopherols are the main forms of vitamin E, an essential fat-soluble nutrient that protects cells from oxidative damage. Getting enough from foods like nuts, seeds, oils, and greens is genuinely necessary. Beyond that the evidence is mixed: the strongest supplement benefit is in fatty liver disease, while higher doses carry real safety signals. Food-level and modest intake are favored. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum alpha-tocopherol | ~30–50 µmol/L | Confirms adequate status and detects deficiency or excess |
| Tocopherol-to-total-cholesterol ratio | >2.5–5.2 µmol/mmol | Corrects vitamin E level for blood lipids, giving a truer status estimate |
| Serum gamma-tocopherol | Detectable, not suppressed | Flags depletion of the anti-inflammatory form during high-dose alpha use |
| ALT and AST (liver enzymes) | ALT <25 U/L (men), <20 U/L (women) | Tracks liver response when tocopherols are used for fatty liver disease |
| INR (clotting time) | Patient-specific (often 2.0–3.0 if anticoagulated) | Detects enhanced bleeding risk in warfarin users |
| PSA (prostate-specific antigen) | <2.5–4.0 ng/mL, stable | Monitors prostate safety in men on high-dose alpha-tocopherol |
Cadence: Little formal monitoring for general low-dose use; for high-dose therapeutic use reassess at ~3 months, then every 6–12 months; check INR within 1–2 weeks of any dose change in anticoagulated patients